BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Envy Medical Release: Clear Acne 3x Faster With ClarityMD Acne System, Newly Unveiled at the American Academy of Dermatology Annual Meeting


2/28/2013 11:00:43 AM

WESTLAKE VILLAGE, Calif., Feb. 28, 2013 /PRNewswire/ -- Envy Medical Inc., expands its skin care offerings beyond the celebrated Lumixyl® System with the launch of the ClarityMD Acne Solutionin what could be the most exciting advancement in acne treatment in decadesat the American Academy of Dermatology Annual Meeting on March 1 in Miami.

The ClarityMD Acne System combines the power of the Deep Pore Cleanser and Clarifying Gel in a two-step system that's clinically proven to significantly heal acne within days. In fact, a recent study shows that ClarityMD clears acne three times faster than the leading over-the-counter and topical acne prescription products on the market today.

Envy Medical, also the makers of the popular SilkPeel® MD, has revolutionized the way acne is treated with their new patent-pending PCX Technology available only in ClarityMD, which features solubilized bakuchiol and bisabolol that together help salicylic acid attack acne at its source while helping to regulate pore-clogging oil production and to reduce inflammation.

The ClarityMD Acne System will be unveiled at booth #369 on the AAD Exhibit floor. Dr. Felipe Jimenez, Envy's Chief Scientific Officer, led the development of this new technology and will be on hand to introduce the system and debut the exciting results from a new clinical study.

Accordingly to the study, the ClarityMD Acne Solution was tested on 25 volunteers that used the Deep Pore Cleanser and Clarifying Gel twice daily over six weeks. After seven days volunteers enjoyed an average 59% reduction in inflammatory acne lesions and a 14% reduction in non-inflammatory acne lesions. After six weeks, 99% of inflammatory and 56% of non-inflammatory acne lesions had been cleared. Plus, unlike benzoyl peroxide- or salicylic acid-based acne products, the results showed that ClarityMD does not dry out skin or cause irritation, redness or peeling.

"Even the best acne products can take up to six weeks to work. However, unpleasant side effects from these regimens, including dryness and irritation, often cause patients to stop using the products prior to getting relief from acne. With the launch of ClarityMD, patients can now rapidly clear their acne in a safe and effective manner," says Curtis A. Cluff, CEO of Envy Medical Inc.

The ClarityMD Acne System will be sold through dermatology, cosmetic surgery and medical spa physicians throughout the United States. The suggested retail price is $49.95 for the two-step system that includes a 6 fl oz Deep Pore Cleanser and a 1 fl oz Clarifying Gel. For more information go to www.claritymdacne.com or contact info@envymedical.com

The American Academy of Dermatology's 71st Annual Meeting will be held in Miami Beach, March 1-5, 2013, at the Miami Beach Convention Center.

ABOUT ENVY MEDICALEnvy Medical develops, markets and sells highly effective non-invasive skin rejuvenation therapies for patients suffering from either dermatologic or aesthetic conditions. The Company's lead products include SilkPeel®, a breakthrough device combining exfoliation with Dermalinfusion for deeper tissue delivery of active ingredients and better patient outcomes. Envy is also the exclusive licensor of skin brightening peptides including Lumixyl, developed at Stanford University. The Lumixyl peptide is available in Envy's Lumixyl Topical Brightening System as well as in a topical solution for SilkPeel procedures, addressing hyperpigmentation and photodamage. More information can be found at www.envymedical.com.

SOURCE Envy Medical Inc.


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->